Loading…
Sotac Pharmaceuticals (SOTAC)₹130.000.00%Pharmaceuticals
At the end of the Mar 2026 quarter, Sotac Pharmaceuticals' shareholders were: promoters 72.88%, FIIs 16.81%, public 10.31%. Promoter holding is unchanged on the quarter. FII holding is up 7.80 percentage points from 9.01% a year earlier. 0.00% of promoter shares were pledged. It had 222 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Promoters | 72.88% | 72.88% | 72.88% | 72.88% | 72.88% | 72.88% | 72.88% |
| FIIs | 12.90% | 8.53% | 9.01% | 8.90% | 15.14% | 16.16% | 16.81% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.68% | 0.00% | 0.00% |
| Public | 14.22% | 18.59% | 18.11% | 18.22% | 11.30% | 10.96% | 10.31% |
| Promoter shares pledged | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 785 | 256 | 246 | 252 | 244 | 241 | 222 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Kiran Baldevbhai Jotania | Promoter | 13.07% | — |
| Vishalkumar Devrajbhai Patel | Promoter | 12.96% | — |
| Dineshkumar Babulal Gelot | Promoter | 12.93% | — |
| Sharadkumar Dashrathbhai Patel | Promoter | 12.93% | — |
| Chetankumar Bachubhai Patel | Promoter | 9.69% | — |
| Nav Capital Vcc - Nav Capital Emerging Star Fund | FII | 7.29% | — |
| Shaileshkumar Vishnuprasad Patel | Promoter | 7.26% | — |
| Craft Emerging Market Fund Pcc- Elite Capital Fund | FII | 7.15% | — |
| Mitul Shaileshkumar Patel | Promoter | 3.27% | — |
| Minerva Ventures Fund | FII | 1.65% | — |
| Kashyapkumar Rajendrakumar Mehta | Public | 1.55% | — |
| Walpar Nutritions Limited | Public | 1.48% | — |
| Dhara Chetankumar Patel | Promoter | 0.16% | — |
| Pinki Sharadkumar Patel | Promoter | 0.16% | — |
| Sarojben Dineshkumar Gelot | Promoter | 0.16% | — |
| Vasantkumar Devrajbhai Patel | Promoter | 0.16% | — |
Promoters held 72.88% of Sotac Pharmaceuticals at the end of the Mar 2026 quarter, the same as a year earlier.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 16.81% (up 0.65 percentage points from 16.16% a quarter earlier) and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
No. The Mar 2026 filing shows no pledged promoter shares.
Sotac Pharmaceuticals had 222 shareholders at the end of the Mar 2026 quarter, against 246 a year earlier.
Nav Capital Vcc - Nav Capital Emerging Star Fund (FII) held 7.29% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.